6.12
薬物クリアランス: 概要
薬物の排泄とは、尿または胆汁を介して、腎臓または肝臓からそれぞれ薬物が体外に除去されることを意味します。薬物動態パラメータである薬物クリアランスは、特定の時間枠内で血流から薬物が除去される効率を測定します。これは、薬物が血漿から除去される速度を血漿中の薬物濃度で割って計算されます。
薬物クリアランス…
体内に入った薬物は、尿または胆汁を通じてそれぞれ腎臓と肝臓によって排除されます。薬物動態パラメータである薬物クリアランスは、特定の期間内に薬物を除去する際の身体の効率を決定します。
薬物クリアランスは、単位時間あたりに一定量の薬物含有液体を除去することと定義されます。これは、血漿からの薬物排出速度を薬物の血漿濃度CPで割ることによって計算されます。
1 次消去中に、消去率を kCpVd に代入すると、クリアランス方程式が変更されます。次の式は、クリアランスが分布の体積 Vd とレート定数 k の積であることを示しています。
その結果、血漿濃度の低下は薬物の排出速度を低下させますが、そのクリアランスは一定のままです。
クリアランスは、合理的な薬物レジメンを設計し、潜在的な副作用を予測する上で重要なパラメータです。
View the full transcript and gain access to JoVE Core videos
Q1: How is drug clearance calculated in pharmacokinetics?
Drug clearance is calculated by dividing the rate of drug elimination from plasma by the drug's plasma concentration. During first-order elimination, clearance equals the product of the volume of distribution and the rate constant. This calculation reveals how efficiently the body removes a fixed volume of drug-containing fluid per unit of time, which remains constant even as plasma concentration decreases.
Q2: What organs are involved in drug clearance?
Drug clearance involves multiple organs including the kidneys, liver, lungs, and biliary system. The kidneys eliminate drugs through urine, while the liver eliminates drugs through bile. The sum of clearances by all eliminating organs is called total body or systemic clearance, which can be expressed as a combination of renal clearance and nonrenal clearance.
Q3: Why does drug clearance remain constant despite changes in plasma concentration?
During first-order elimination, clearance is defined as the product of the volume of distribution and rate constant, making it independent of plasma concentration. Although a decrease in plasma concentration reduces the drug elimination rate, the clearance value itself stays constant because it represents the body's inherent capacity to remove the drug, not the absolute amount removed.
Q4: What happens when dosing rate exceeds the body's elimination capacity?
Exceeding the prescribed dosing rate overloads elimination pathways and decreases drug clearance efficiency. This leads to elevated plasma drug concentrations that can reach toxic levels and cause adverse effects. Understanding drug clearance is essential for designing effective dosage regimens and ensuring safe, optimal drug therapy tailored to individual needs.
Q5: How does drug clearance relate to drug regimen design?
Drug clearance is a crucial pharmacokinetic parameter for designing rational drug regimens and predicting potential side effects. By measuring the body's efficiency in removing drugs within a specific period, clinicians can determine appropriate dosing intervals and amounts. This allows for individualized adjustments based on a person's specific elimination capacity and needs.
Q6: What is the difference between renal and nonrenal clearance?
Renal clearance refers to drug elimination through the kidneys via urine, while nonrenal clearance encompasses elimination through other organs like the liver, lungs, and biliary system. Total body clearance is the sum of both renal and nonrenal clearance pathways. Understanding both components helps predict how individual organ function affects overall drug removal.
Q7: How do physicochemical properties influence drug clearance?
A drug's physicochemical properties affect how efficiently it is eliminated by the body's organs. These properties influence whether a drug undergoes renal excretion, hepatic metabolism, or other elimination pathways. Understanding factors affecting renal clearance drug's physicochemical properties and plasma levels helps predict clearance rates and optimize dosing strategies for different patient populations.